Spots Global Cancer Trial Database for Embryonic Ploidy Status in the Oncofertility Population

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Embryonic Ploidy Status in the Oncofertility Population

Official Title: Embryonic Ploidy Status in the Oncofertility Population

Study ID: NCT03350230

Conditions

Oncology

Fertility

Interventions

Study Description

Brief Summary: looking at aneuploidy rates in embryos from patients who are going to or have undergone treatment for a malignancy with gonadotoxic treatment.

Detailed Description: The study involves oncofertility patients--individuals who are undergoing or have undergone therapy for a malignancy--who are interested in pursuing or preserving fertility. In particular, it investigates chromosomal abnormalities or aneuploidy in the embryos of those individuals as compared to the general infertility population. Embryonic aneuploidy is largely due to reproductive senescence. As such the investigators will discuss oncofertility prevalence and treatment as well as reproductive senescence and assessment of embryonic aneuploidy. The study will seek to determine if there are changes in embryonic aneuploidy rates in oncofertility patients that differ from simple age related risks.